About Jack Lief
Jack Lief is a director at CeleCor Therapeutics.
Jack Lief first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Jack Lief in the role, so the role may have started earlier or lasted longer.
CeleCor Therapeutics, Inc.
Director
2021 – 2026 · Del Mar, CA
Develops an investigational drug for early treatment of severe heart attacks.
Key Colleagues at Startups
The people Jack Lief works with at each company, as listed on that company's latest Form D.
CeleCor Therapeutics, Inc. · Form D, Jul 9, 2026